Colonic tumors

Endoscopy

Volumn 30, Issue 2, 1998, Pages 150-157

  Bond, J H ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SULINDAC;

BARRETT ESOPHAGUS; CHOLECYSTECTOMY; COLON POLYP; COLON TUMOR; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC POLYPECTOMY; GASTRECTOMY; GENETIC LINKAGE; HUMAN; MOLECULAR GENETICS; ONCOGENE K RAS; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0031978374     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1001241     Document Type: Review

References (63)

1. Reid FD, Mercer PM, Harrison M, Bates T. Cholecystectomy as a risk factor for colorectal cancer: A meta-analysis. Scand J Gastroenterol 1996; 31: 160-9.
2. Poorman JC, Lieberman DA, Ippoliti AF, et al. The prevalence of colonic neoplasia in patients with Barrett's esophagus: Prospective assessment in patients 50-80 years old. Am J Gastroenterol 1997; 92: 592-6.
3. Munnangi S, Sonnenberg A. Colorectal cancer after gastric surgery: A meta-analysis. Am J Gastroenterol 1997; 92: 109-13.
4. Fante R, Roncucci L, Digregorio C, et al. Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma. Cancer 1996; 77: 2013-21.
5. Passman MA, Pommier RF, Vetto JT. Synchronous colon primaries have the same prognosis as solitary colon cancers. Dis Colon Rectum 1996; 39: 329-34.
6. Chak A, Post AB, Cooper GS. Clinical variables associated with colorectal cancer on colonoscopy: A prediction model. Am J Gastroenterol 1996; 99: 2478-88.
7. Samowitz WS, Slattery ML. Microsatellite instability in colorectal adenomas. Gastroenterology 1997; 112: 1515-9.
8. HER-2/neu correlates with the stage of disease and survival in colorectal cancer. Gastroenterology 1997; 112: 1103-13.
9. Hammel P, Boissier B, Chaumette M-T, et al. Detection and monitoring of serum p53 antibodies in patients with colorectal cancer. Gut 1997; 40: 356-61.
10. Anker P, Lefort F, Vasioukhin V, et al. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 1997; 112: 1114-20.
11. Sidransky D, Tokino T, Hamilton SR, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992; 256: 102-4.
12. Villa E, Dugani A, Rebecchi AM, et al. Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool. Gastroenterology 1996; 110: 1346-53.
13. Giardiello FM, Offerhaus JA, Tersmette AC, et al. Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: Evaluation of predictive factors. Gut 1996; 38: 578-81.
14. Matsuhashi N, Nakajima A, Fukushima Y, et al. Effects of sulindac on sporadic colorectal adenomatous polyps. Gut 1997; 40: 344-9.
15. Burt RW: Update on genetic advances in colorectal cancer. Pract Gastroenterol 1997; 21: 9-20.
16. Mills SJ, Chapman PD, Burn J, et al. Endoscopic screening and surgery for familial adenomatous polyposis: Dangerous delays. Br J Surg 1997; 84: 74-7.
17. Levi E, Stryker SJ, Rao MS. p53 protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: Is it an early or late event? Am J Gastroenterol 1996; 91: 11-14.
18. Karner-Hanusch J, Wolf B, Zehetmayer M, et al. Screening by genomic linkage studies and mutation analysis of hereditary adenomatous polyposis coli: Usefulness for clinical practice. World J Surg 1996; 20: 578-83.
19. Debinski HS, Love S, Spigelman AD, et al. Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology 1996; 110: 1028-30.
20. Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996; 110: 1020-7.
21. Watanabe T, Muto T, Sawada T, et al. Flat adenoma as a precursor of colorectal carcinoma in hereditary nonpolyposis colorectal carcinoma. Cancer 1996; 77: 627-34.
22. Aitken JF, Bain CJ, Ward M, et al. Risk of colorectal adenomas in patients with a family history of colorectal cancer: Some implications for screening programmes. Gut 1996; 39: 105-8.
23. Winawer JS, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 1996; 334: 82-7.
24. Moss SF, Liu TC, Petrotos A, et al. Inward growth of colonic adenomatous polyps. Gastroenterology 1996; 111: 1425-32.
25. Hofstad B, Vatn MH, Andersen SN, et al. Growth of colorectal polyps: Redetection and evaluation of unresected polyps for a period of three years. Gut 1996; 39: 449-56.
26. Otchy DP, Ransohoff DF, Wolff BG, et al. Metachronous colon cancer in persons who have had a large adenomatous polyp. Am J Gastroenterol 1996; 91: 448-54.
27. Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology 1996; 110: 748-55.
28. Burt RW, Samowitz WS. Serrated adenomatous polyposis: A new syndrome? Gastroenterology 1996; 110: 950-2.
29. Binmoeller KF, Bohnacker S, Seifert H, et al. Endoscopic snare excision of "giant" colorectal polyps. Gastrointest Endose 1996; 43: 183-8.
30. Kanamori T, Itoh M, Yokoyama Y, et al. Injection-incision: Assisted snare resection of large sessile colorectal polyps. Gastrointest Endosc 1996; 43: 189-95.
31. Gibbs DH, Opelka FG, Beck DE, et al. Postpolypectomy colonic hemorrhage. Dis Colon Rectum 1996; 39: 806-10.
32. Folwaczny C, Heldwein W, Obermaier G, et al. Influence of prophylactic local administration of epinephrine on bleeding complications after polypectomy. Endoscopy 1996; 28: 31-3.
33. Iishi H, Tatsuta M, Narahara H, et al. Endoscopic resection of large pedunculated colorectal polyps using a detachable snare. Gastrointest Endosc 1996; 44: 594-7.
34. Nizam R, Siddiqi N, Landas SK, et al. Colonic tattooing with India ink: Benefits, risks, and alternatives. Am J Gastroenterol 1996; 91: 1804-8.
35. Iishi H, Tatsuta M, Yano H, et al. More effective endoscopic resection with a two-channel colonoscope for carcinoid tumors of the rectum. Dis Colon Rectum 1196; 39: 1438-9.
36. Rex DK, Rahmani EY, Haseman JH, et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997; 112: 17-23.
37. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112: 24-8.
38. Axelrad AM, Fleischer DE, Geller AJ, et al. High-resolution chromoendoscopy for the diagnosis of diminutive colon polyps: Implications for colon cancer screening. Gastroenterology 1996; 110: 1253-8.
39. Wang TD, Van-Dam J, Crawford JM, et al. Fluorescence endoscopic imaging of human colonic adenomas. Gastroenterology 1996; 111: 1182-91.
40. Hara AK, Johnson CD, Reed JE, et al. Detection of colorectal polyps by computed tomographic colography: Feasibility of a novel technique. Gastroenterology 1996; 110: 284-90.
41. Spinzi GC, Belloni GM, Martegani A, et al. CT-based virtual endoscopy: Comparison with colonoscopy (abstract). Gastrointest Endosc 1997; 45: AB39.
42. Rex D, Vining D, Kopecky K. Screening for colon polyps using spiral CT with and without virtual colonoscopy (abstract). Gastrointest Endosc 1997; 45: AB116.
43. Byers T, Levin B, Rothenberger D, et al. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997. CA-Ca J Clinicians 1997; 47: 154-60.
44. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642.
45. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. Report of the U.S. Preventive Services Task Force. 2nd ed. Washington, DC: Government Printing Office, 1996.
46. Levin B, Bond JH. Colorectal cancer screening: Recommendations of the U.S. Preventive Services Task Force. Gastroenterology 1996; 111: 1381-4.
47. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
48. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71.
49. Mandel JS, Bond JH, Church TR, et al. Screening for fecal occult blood reduces mortality from colorectal cancer: Results from the Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-71.
50. Winawer SJ, Flehinger BJ, Schottenfeld D, et al. Screening for colorectal cancer with fecal occult blood test and sigmoidoscopy. J Natl Cancer Inst 1993; 85: 1311-8.
51. Kewenter J, Bjork S, Haglind E, et al. Screening and rescreening for colorectal cancer: A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 1988; 62: 645-51.
52. Allison JE, Tekawa IS, Ransom LJ, et al. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334: 155-9.
53. Kewenter J, Brevinge H. Endoscopic and surgical complications of work-up in screening for colorectal cancer. Dis Colon Rectum 1996; 39: 676-80.
54. Rex DK, Cummings OW, Helper DJ, et al. 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons. Gastroenterology 1996; 111: 1178-81.
55. Foutch PG, Mai H, Pardy K, et al. Flexible sigmoidoscopy may be ineffective for secondary prevention of colorectal cancer in asymptomatic average-risk men. Dig Dis Sci 1991; 36: 924-8.
56. Lieberman D, Smith F: Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991; 86: 946-51.
57. Rex D, Lehman G, Hawes R, et al. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology 1991; 100: 64-7.
58. Lemmel GT, Haseman JH, Rex DK, et al. Neoplasia distal to the splenic flexure in patients with proximal colon cancer. Gastrointest Endosc 1996; 44: 109-11.
59. Read TE, Read JD, Butterly LF. Importance of adenomas 5 mm or less in diameter that are detected by sigmoidoscopy. N Engl J Med 1997; 336: 8-12.
60. Khoury DA, Opelka FG, Beck DE, et al. Colon surveillance after colorectal cancer surgery. Dis Colon Rectum 1996; 39: 252-6.
61. Barillari P, Ramacciato G, Manetti G, et al. Surveillance of colorectal cancer: Effectiveness of early detection of intraluminal recurrences on prognosis and survival of patients treated for cure. Dis Colon Rectum 1996; 39: 388-93.
62. Neugut AI, Lautenbach E, Abi-Rached B, et al. Incidence of adenomas after curative resection for colorectal cancer. Am J Gastroenterol 1996; 91: 2096-8.
63. Bruinvels DJ, Stiggelbout AM, Klaassen MP, et al. Follow-up after colorectal cancer: Current practice in The Netherlands. Eur J Surg 1995; 161: 827-31.